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BACKGROUND Few studies have quantiﬁed resource utilization or
costs after percutaneous coronary intervention (PCI) on a population
level. Understanding variation in resource use is necessary to improve
the quality of care for this population.
METHODS We conducted a retrospective cohort study of patients >20
years old receiving an incident PCI between Jan 2008 to Dec 2012 in Kaiser
Permanente Northern California, a large, integrated health care system
caring for >3.7M persons. We calculated crude rates of repeat revascular-
ization (PCI and CABG), resource utilization (overall and coronary heart
disease (CHD)-related hospitalization, emergency room (ER) visits, and
outpatient visits), and CHD-related health care costs through Dec 2013.
Results were stratiﬁed by (1) gender, (2) diabetes status and (3) patients
with recurrent CHD-related symptoms, which included those with repeat
stress testing or anti-anginal medication use after PCI.
RESULTS Of 16,665 patients identiﬁed with incident PCI (mean age 66
years), 29% were women, 30% had diabetes mellitus, and 59%
received PCI in the setting of an acute coronary syndrome. In the ﬁrst
12 months after incident PCI, 8% had repeat PCI, 25% had a stress test,
20% had a CHD-related hospitalization, and 33% had a CHD-related ER
visit. During mean follow up of 3.0 years, rates (per 100 person-years)
of repeat PCI were substantially higher for patients with diabetes and
for those with CHD-related symptoms, but were similar for men and
women (see Table). Rates of stress testing after PCI were substantially
higher for those with CHD-related symptoms, but not meaningfully
different for diabetic and female subgroups. CHD-related hospitali-
zations, CHD-related ER and CHD-related costs were substantially
higher for all three subgroups (see Table and Figure).
Table. Crude rates of post-PCI resource utilization by subgroupsPatients
at riskRepeat PCI Stress TestingCHD-related
hospitalization CHD-related ER visitsEvents/
100
person-
years 95 % CIEvents/
100
person-
years 95 % CIEvents/
100
person-
years 95 % CIEvents/
100
person-
years 95 % CIOverall 16665 5.6 (5.4-5.9) 21.0 (20.6-21.3) 17.5 (17.2-17.9) 50.3 (49.7-50.9)Women 4821 5.4 (5.0-5.8) 20.4 (19.7-21.2) 21.7 (20.9-22.4)* 65.1 (63.8-66.4)*Men 11844 5.7 (5.5-6.0) 21.2 (20.7-21.6) 15.9 (15.5-16.4)* 44.4 (43.7-45.1)*Diabetes 5007 8.2 (7.7-8.6)* 20.1 (19.4-20.9)* 28.3 (27.4-29.2)* 64.6 (63.3-66.0)*No diabetes 11658 4.6 (4.4-4.9)* 21.3 (20.8-21.7)* 13.3 (13.0-13.7)* 44.7 (44.0-45.4)*CHD-related
symptoms6390 8.3 (7.9-8.7)* 39.2 (38.5-40.0)* 24.2 (23.6-24.9)* 68.6 (67.6-69.7)*No CHD-
related
symptoms9735 3.2 (3.0-3.4)* 4.2 (4.0-4.5)* 11.4 (11.0-11.9)* 33.5 (32.8-34.2)**p < 0.05CONCLUSIONS Among patients with incident PCI, resource utiliza-
tion and costs were generally higher among female patients and those
with diabetes, and substantially higher among those with recurrent
CHD-related symptoms. Research to identify mechanisms driving
excess resource utilization is warranted.
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BACKGROUND Currently, provisional approach is recommended to
treat most of coronary bifurcation lesions. However, it is associated
with the risk of side branch (SB) occlusion after main vessel (MV)
stenting due to plaque or carina shift into the SB. The SB occlusion
may cause peri-procedural myonecrosis or hemodynamic compro-
mise. Therefore, strategies are needed to reduce the SB occlusion
during provisional approach. We proposed a new technique for the
treatment of coronary bifurcation lesions, called jailed semi-inﬂated
balloon technique (JSBT).
METHODS We selected 137 patients with 148 distinct coronary bifur-
cation lesions underwent PCI using JSBT. All patients were followed
with hospital visits or telephone contact up to 1 month. Procedure:-
Steps of this technique were illustrated in Figure 1. 1. The procedure
starts with wiring of both branches. 2. A standard coronary stent is
advanced to cover the MV lesion and then a standard semi-compliant
balloon is advanced into the SB. The proximal markers of the SB
balloon and MV stent balloon are aligned (Figure 1A); 3. The
SB balloon is inﬂated to low pressure (3 atmospheres) (Figure 1B); 4.
Then, the MV stent balloon is inﬂated with nominal pressures. During
inﬂation of MV stent balloon, proximal part of jailed SB balloon is
compressed and contrast is squeezed, overinﬂating the distal part of
the balloon at the SB ostium. Thus the jailed semi-inﬂated balloon is
prevent plaque or carina shift into the SB ostium due to its full
occupation of the SB ostium. 5. Both MV stent balloon and SB balloon
are deﬂated together and removed (Figure 1D); 6. For optimization of
MV stent apposition, POT is performed with a short non-compliant
balloon (Figure 1E); 7. Final angiogram (Figure 1F).
RESULTS The majority of the patients had acute coronary syndrome
(64.2%) and Medina 1.1.1. bifurcation lesions (62.8%). After the MV
stenting, TIMI 3 ﬂow was established in 100% of both MV and SB.
There was no SB occlusion in any patient. There was no major adverse
cardiac event during in-hospital stay and one month follow-up.
CONCLUSIONS This new JSBT technique provides high rate of pro-
cedural success, excellent SB protection during MV stenting and early
clinical outcome. However, additional multicenter randomized
studies with larger sample sizes and longer follow-up are necessary to
establish the long-term safety and efﬁcacy of this technique.
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BACKGROUND Repeat revascularization following percutaneous
coronary intervention (PCI) is a common end-point in clinical studies
which may reﬂect restenosis, myocardial infarction or stent throm-
bosis events. However, the association between repeat revasculari-
zation and long-term mortality is poorly deﬁned. We explored the
relationship between target vessel revascularization (TVR) and long-
term mortality following PCI.
METHODS We analyzed mortality in 41,180 patients following their
ﬁrst index PCI procedure between 2008-2014 who were enrolled in the
British Columbia Cardiac Registry. Cox proportional hazard models
were built to determine the association between TVR (30 days, 1
month, 6 months, 1 year and 2 years) and long-term mortality at 3
years.
RESULTS A total of 5,554 patients (13.4%) received TVR during the
study period. The TVR rates for 30 days, 3 months, 6 months, 1 year
and 2 years were 2.4%, 3.4%, 4.9%, 6.6% and 8.5% respectively. The 3-
year mortality rates according to whether they had TVR versus no TVR
are shown in table 1. Multivariable-adjusted analyses identiﬁed TVR
at 30 days as a strong predictor for 3-year mortality (HR¼1.64, 95% CI:
1.36-1.98, p<0.001). This association persisted for TVR at 1 year
(HR¼1.17, 95% CI: 1.03-1.33, p¼0.013), but was lost for TVR at 2 years(HR¼1.07, 95% CI: 0.95-1.20, p¼0.269). The trends in HRs are shown in
ﬁgure 1.
CONCLUSIONS In this large cohort of unselected patients undergoing
PCI, early TVR was a strong independent predictor of long-term
mortality. This association became less strong with progressively later
TVR events. These data suggest that TVR events are not benign, and
might help explain late mortality events in clinical studies.
Table 1Follow-up periodCumulative TVR
rate (%)3 year mortality (%)TVR group No TVR group p value30 days 2.4 13.3 7.7 <0.0013 months 3.4 11.9 7.7 <0.0016 months 4.9 11.1 7.6 <0.0011 year 6.6 10.3 7.6 <0.0012 years 8.5 9.3 7.7 0.748CATEGORIES CORONARY: PCI Outcomes
KEYWORDS Mortality, long-term, Percutaneous coronary interven-
tion, Target vessel revascularization
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BACKGROUND The real world generalizability of clinical trials has
come under increasingly intense scrutiny. While patients participating
in clinical trials are of a lower risk proﬁle, they are followed up more
closely post percutaneous coronary intervention (PCI). We wanted to
discern whether enrollment in interventional cardiovascular clinical
trials translates to better or worse outcomes following PCI.
METHODS A single-center analysis was done of patients undergoing
PCI between 1/1/2010 and 12/31/2013 (n ¼ 14,075). Out of this cohort,
4.7% (n ¼ 659) were enrolled in a clinical trial. We compared those
enrolled versus not in clinical trials and analyzed for baseline and
procedural characteristics, death, myocardial infarction (MI), target
vessel revascularization (TVR), and major adverse cardiovascular
events (MACE).
RESULTS Patients enrolled in clinical trials were younger, had a bet-
ter left ventricular ejection fraction (LVEF), lower creatinine, and a
